Shopping Cart
- Remove All
- Your shopping cart is currently empty
HIV-1 inhibitor-40 (Compound 4ab), an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) with an EC50 of 1.9 nM, exhibits no significant acute toxicity in vivo and functions as a highly sensitive inhibitor of the orexin receptor antagonist CYP.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 10-14 weeks | |
50 mg | $1,980 | 10-14 weeks | |
100 mg | $2,500 | 10-14 weeks |
Description | HIV-1 inhibitor-40 (Compound 4ab), an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) with an EC50 of 1.9 nM, exhibits no significant acute toxicity in vivo and functions as a highly sensitive inhibitor of the orexin receptor antagonist CYP. |
Targets&IC50 | K103N:0.004 μM (EC50), CYP2C9:5.16 μM, Y188L:0.570 μM (EC50), HIV-1 (WT):1.9 nM (EC50), L100I:0.019 μM (EC50), CYP2C19:4.51 μM, Y181C:0.029 μM (EC50), E138K:0.009 μM (EC50) |
Molecular Weight | 434.45 |
Formula | C25H18N6O2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.